Autopsy report · NCT00731874
Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status
Cause of deathSlow enrollment
“A higher rate of late rejection was seen in the low tacrolimus arm.”
Life of this trial
- Ran for about 4 years 11 months before it stopped.
- 34 participants enrolled.
- Results were posted on the registry 2 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University, hospital or other
- Conditions
- Immunosuppression
- Interventions
- Tacrolimus
- Participants
- 34
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.